المؤلفون: Kreutziger J; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at., Ulmer H; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at., Fries D; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 772-773.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods , Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects, Humans ; Clinical Trials, Phase IV as Topic ; Randomized Controlled Trials as Topic ; Rivaroxaban/adverse effects ; Multicenter Studies as Topic ; Research Design

المؤلفون: Yates SG; University of Texas Southwestern Medical Center, Dallas, TX sean.yates@utsouthwestern.edu., Sarode R; University of Texas Southwestern Medical Center, Dallas, TX sean.yates@utsouthwestern.edu.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 773-774.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects , Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods, Humans ; Rivaroxaban/adverse effects ; Multicenter Studies as Topic ; Clinical Trials, Phase IV as Topic ; Research Design ; Randomized Controlled Trials as Topic

المؤلفون: Wong ML; Lewis Katz School of Medicine at Temple University, Philadelphia, PA matthew.wong@tuhs.temple.edu.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 773.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods , Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects, Humans ; Clinical Trials, Phase IV as Topic ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Research Design ; Rivaroxaban/adverse effects

المؤلفون: Shoamanesh A; McMaster University, Hamilton, ON, Canada., Sharma M; McMaster University, Hamilton, ON, Canada.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8).

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods , Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects, Humans ; Clinical Trials, Phase IV as Topic ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Research Design ; Rivaroxaban/adverse effects

المؤلفون: Douketis JD; Department of Medicine, St. Joseph's Healthcare Hamilton, and McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada., Spyropoulos AC; Department of Medicine, Anticoagulation and Clinical Thrombosis Service, Northwell Health at Lenox Hill Hospital, New York, New York.; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.; Institute of Health System Science at the Feinstein Institutes for Medical Research, Manhasset, New York.

المصدر: JAMA [JAMA] 2024 Sep 10; Vol. 332 (10), pp. 825-834.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulants*/administration & dosage , Anticoagulants*/adverse effects , Anticoagulants*/blood , Perioperative Care*/methods , Blood Loss, Surgical*/prevention & control , Postoperative Hemorrhage*/chemically induced , Postoperative Hemorrhage*/epidemiology , Postoperative Hemorrhage*/prevention & control , Anticoagulation Reversal*/methods, Humans ; Administration, Oral ; Atrial Fibrillation/drug therapy ; Pyridines/administration & dosage ; Pyridines/adverse effects ; Pyridines/blood ; Rivaroxaban/administration & dosage ; Rivaroxaban/adverse effects ; Rivaroxaban/blood ; Venous Thromboembolism/drug therapy ; Dabigatran/administration & dosage ; Dabigatran/adverse effects ; Dabigatran/blood ; Thiazoles/administration & dosage ; Thiazoles/adverse effects ; Thiazoles/blood ; Elective Surgical Procedures/adverse effects

المؤلفون: Procopio GL; Department of Pharmacy, Hackensack University Medical Center, Hackensack, NJ, 07601, USA. gabrielle.procopio@gmail.com.; Department of Emergency Medicine, Hackensack Meridian School of Medicine, Nutley, NJ, 07110, USA. gabrielle.procopio@gmail.com., Jain RP; Department of Pharmacy, Hackensack University Medical Center, Hackensack, NJ, 07601, USA., Bicking K; Department of Pharmacy, Hackensack University Medical Center, Hackensack, NJ, 07601, USA., Tompkins DM; Department of Pharmacy, Hackensack University Medical Center, Hackensack, NJ, 07601, USA.; Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, 08854, USA.

المصدر: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2024 Jan; Vol. 57 (1), pp. 175-177. Date of Electronic Publication: 2023 Aug 29.

نوع المنشور: Letter

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacists* , Anticoagulation Reversal*, Humans ; Blood Coagulation Factors ; Anticoagulants/therapeutic use ; Academic Medical Centers ; Factor Xa ; Recombinant Proteins ; Factor Xa Inhibitors ; Retrospective Studies

المؤلفون: Koo SJ, Hussain Y, Booth DY, Desai P, Oh ES, Rios J, Audley K

المصدر: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 Mar-Apr; Vol. 64 (2), pp. 395-401. Date of Electronic Publication: 2023 Nov 11.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1544-3450 (Electronic) Linking ISSN: 10865802 NLM ISO Abbreviation: J Am Pharm Assoc (2003) Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal* , Blood Coagulation Factors*/adverse effects , Blood Coagulation Factors*/therapeutic use , Factor Xa* , Hemostatics*/adverse effects , Hemostatics*/therapeutic use , Recombinant Proteins*/adverse effects , Recombinant Proteins*/therapeutic use, Adult ; Humans ; Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Factor Xa Inhibitors/adverse effects ; Factor Xa Inhibitors/therapeutic use ; Hemorrhage/chemically induced ; Hemorrhage/drug therapy ; Retrospective Studies

المؤلفون: Llagostera Martín, Marc

مرشدي الرسالة: Vaquerizo Montilla, Beatriz, Cubero Gallego, Héctor, Farré López, Núria

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Orelleta esquerra, Atrial appendage, Orejuela izquierda, Fibril·lacio auricular, Atrial fibrillation, Fibrilación auricular, Anticoagulació, Anticoagulation, Anticoagulación, Ciències de la Salut

Time: 616.1

وصف الملف: application/pdf

URL الوصول: http://hdl.handle.net/10803/691689

المؤلفون: Otero J; From the Clinical Pharmacist, Seattle Children's Hospital., Mazor SS; Professor, Toxicology Seattle Children's Hospital, University of Washington School of Medicine., Leoni J; Assistant Professor, Seattle Children's Hospital, Harborview Medical Center, University of Washington School of Medicine, Seattle, WA.

المصدر: Pediatric emergency care [Pediatr Emerg Care] 2022 Nov 01; Vol. 38 (11), pp. 621-625.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8507560 Publication Model: Print Cited Medium: Internet ISSN: 1535-1815 (Electronic) Linking ISSN: 07495161 NLM ISO Abbreviation: Pediatr Emerg Care Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal* , Anticoagulants*/adverse effects, Adult ; Humans ; Child ; Administration, Oral ; Warfarin ; Emergency Service, Hospital

المصدر: Pediatric emergency care [Pediatr Emerg Care] 2022 Nov 01; Vol. 38 (11), pp. 626-627.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8507560 Publication Model: Print Cited Medium: Internet ISSN: 1535-1815 (Electronic) Linking ISSN: 07495161 NLM ISO Abbreviation: Pediatr Emerg Care Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal* , Anticoagulants*/adverse effects, Child ; Humans ; Emergency Service, Hospital ; Administration, Oral